Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 300 participants.

Also called NCT05268094

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05268094
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05268094. Randomized; no masking; primary purpose treatment. Start 2022-06-02 (actual); primary completion 2027-09-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)
Acronym
COMPASS
Condition
Congenital Heart Disease in Children
Intervention (Device)
Ductal Arterial Stent
Intervention (Procedure)
Systemic-to-Pulmonary Artery Shunt
Lead sponsor
Carelon Research (class: other)
Collaborator
Pediatric Heart Network (class: other)

Record details

Record id
cardio:ct-nct05268094
Content hash
7d911515b12e02b284b8f04b5927938f0ae746d1c4ccb1cec7bc5789353a240c